Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Local Disparities in Breastfeeding Initiation and Duration: A Cross-Sectional Population-Based Survey in Ten Chicago Community Areas.

Hughes MM, Saiyed NS, Roesch PT, Masinter L, Sarup A.

J Community Health. 2019 Aug;44(4):629-635. doi: 10.1007/s10900-018-00597-3.

PMID:
30569222
2.

Effect of corneal hydration on ultrasound velocity and backscatter.

Silverman RH, Patel MS, Gal O, Sarup A, Deobhakta A, Dababneh H, Reinstein DZ, Feleppa EJ, Coleman DJ.

Ultrasound Med Biol. 2009 May;35(5):839-46. doi: 10.1016/j.ultrasmedbio.2008.11.009. Epub 2009 Feb 5.

3.

Effect of topiramate and dBcAMP on expression of the glutamate transporters GLAST and GLT-1 in astrocytes cultured separately, or together with neurons.

Poulsen CF, Schousboe I, Sarup A, White HS, Schousboe A.

Neurochem Int. 2006 May-Jun;48(6-7):657-61. Epub 2006 Mar 9.

PMID:
16524645
4.

Effect of hyperosmotic conditions on the expression of the betaine-GABA-transporter (BGT-1) in cultured mouse astrocytes.

Olsen M, Sarup A, Larsson OM, Schousboe A.

Neurochem Res. 2005 Jun-Jul;30(6-7):855-65.

PMID:
16187220
5.

Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues.

Clausen RP, Moltzen EK, Perregaard J, Lenz SM, Sanchez C, Falch E, Frølund B, Bolvig T, Sarup A, Larsson OM, Schousboe A, Krogsgaard-Larsen P.

Bioorg Med Chem. 2005 Feb 1;13(3):895-908.

PMID:
15653355
6.

First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.

White HS, Watson WP, Hansen SL, Slough S, Perregaard J, Sarup A, Bolvig T, Petersen G, Larsson OM, Clausen RP, Frølund B, Falch E, Krogsgaard-Larsen P, Schousboe A.

J Pharmacol Exp Ther. 2005 Feb;312(2):866-74. Epub 2004 Nov 18.

PMID:
15550575
7.

Role of the betaine/GABA transporter (BGT-1/GAT2) for the control of epilepsy.

Schousboe A, Larsson OM, Sarup A, White HS.

Eur J Pharmacol. 2004 Oct 1;500(1-3):281-7. Review.

PMID:
15464040
8.

GABA transporters as drug targets for modulation of GABAergic activity.

Schousboe A, Sarup A, Larsson OM, White HS.

Biochem Pharmacol. 2004 Oct 15;68(8):1557-63.

PMID:
15451399
9.

Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission.

Schousboe A, Sarup A, Bak LK, Waagepetersen HS, Larsson OM.

Neurochem Int. 2004 Sep;45(4):521-7. Review.

PMID:
15186918
10.

GABA transporters and GABA-transaminase as drug targets.

Sarup A, Larsson OM, Schousboe A.

Curr Drug Targets CNS Neurol Disord. 2003 Aug;2(4):269-77. Review.

PMID:
12871037
11.
12.

GDNF pre-treatment aggravates neuronal cell loss in oxygen-glucose deprived hippocampal slice cultures: a possible effect of glutamate transporter up-regulation.

Bonde C, Sarup A, Schousboe A, Gegelashvili G, Noraberg J, Zimmer J.

Neurochem Int. 2003 Sep-Oct;43(4-5):381-8.

PMID:
12742082
13.

Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions.

Bonde C, Sarup A, Schousboe A, Gegelashvili G, Zimmer J, Noraberg J.

Neurochem Int. 2003 Sep-Oct;43(4-5):371-80.

PMID:
12742081
14.

Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.

White HS, Sarup A, Bolvig T, Kristensen AS, Petersen G, Nelson N, Pickering DS, Larsson OM, Frølund B, Krogsgaard-Larsen P, Schousboe A.

J Pharmacol Exp Ther. 2002 Aug;302(2):636-44.

PMID:
12130726
15.

Psychological assessment of blood related renal donors.

Varma VK, Yadav RV, Sharma K, Sarup A.

Indian J Med Res. 1992 Jun;96:182-5.

PMID:
1512042

Supplemental Content

Support Center